Latent Tuberculosis Infection in Korean Health Care Workers
1 other identifier
interventional
240
1 country
1
Brief Summary
The investigators aim to study the prevalence of latent tuberculosis infection (LTBI) using whole-blood interferon-r release assays, and determine the risk factors of LTBI in Korean health care workers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 17, 2016
CompletedFirst Posted
Study publicly available on registry
January 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJanuary 4, 2017
January 1, 2017
1 year
December 17, 2016
January 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of latent tuberculosis infection developed in Korean health care workers
The participants performed QuaniFERON-TB Gold In-Tube test (QFT-IT test) and blood sampling at enrollment. So, the length of time which from the start of the first test of very first participants to the end of test of very last participant is 3 months. The percentage of participants with LTBI in health care workers was evaluated.
Three months
Secondary Outcomes (1)
Annual incidence of latent tuberculosis infection in Korean health care workers
1 year after first QFT-IT test (12-15 months)
Study Arms (1)
health care workers
OTHERhealth care workers including doctors, nurses, technicians and orderly who were hired in 2016 at the Hanyang University Hospital
Interventions
In all enrolled health care workers, QFT-IT Test and other blood sampling were performed.
Eligibility Criteria
You may qualify if:
- Health care workers in University affiliated hospital
- Adult aged 20-65
You may not qualify if:
- Active tuberculosis
- Subjects diagnosed with HIV infection, malignancy
- Subjects having immunosuppressive drug therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hanyang University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jang Won Shon, M.D., Ph.D.
Hanyang University Hospital, Seoul, Korea
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
December 17, 2016
First Posted
January 4, 2017
Study Start
December 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
January 4, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share